Trial Profile
An open label, multiple dose, Phase III clinical study in patients with prostate cancer to investigate the clinical efficacy of AMW goserelin 3.6 mg implant in its application system
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 28 Jul 2016
Price :
$35
*
At a glance
- Drugs Goserelin (Primary)
- Indications Prostate cancer
- Focus Registrational; Therapeutic Use
- Sponsors AMW GmbH
- 27 Jul 2016 Status changed from recruiting to completed.
- 16 Mar 2016 New trial record